Table 2 Assessment of economic evaluations according to the CHEERS reporting guidelines
From: Menopausal hormone therapy: a systematic review of cost-effectiveness evaluations
Item No | Sectiona | Salpeter et al. 2009 [41] | Lekander et al. 2009a [42] | Lekander et al. 2009b [43] | Ylinkangas et al. 2007 [44] | Zethraeus et al. 2005 [45] |
|---|---|---|---|---|---|---|
| Â | Title and abstract | |||||
1 | In title identify study as an economic evaluation, or use relevant terms & describe interventions compared | incomplete | incomplete | incomplete | incomplete | incomplete |
2 | Provide structured summary in the abstract with specified subheadings | incomplete | incomplete | incomplete | incomplete | incomplete |
| Â | Introduction | |||||
3 | Provide explicit statement of broader context, state study question & relevance for public policy or practice decisions | incomplete | incomplete | incomplete | incomplete | incomplete |
| Â | Methods | |||||
4 | Target population: describe base case population & subgroups analysed including why they were chosen | incomplete | incomplete | incomplete | yes | incomplete |
5 | Setting and location: state relevant aspects of the system(s) in which the decision(s) need(s) to be made | no | no | no | no | no |
6 | Describe the study perspective & relate this to the costs evaluated | yes | incomplete | yes | incomplete | incomplete |
7 | Describe the comparators and state why they were chosen | incomplete | incomplete | incomplete | yes | incomplete |
8 | State the time horizon(s) over which costs & consequences are evaluated & say why appropriate | incomplete | incomplete | incomplete | incomplete | incomplete |
9 | Report the choice of discount rate(s) used for costs & outcomes; say why appropriate | incomplete | incomplete | incomplete | incomplete | incomplete |
10 | Describe choice of health outcomes & their relevance for the type of analysis performed | incomplete | yes | yes | yes | incomplete |
11 | Describe fully the methods used for identification of included studies & synthesis of clinical effectiveness data | incomplete | incomplete | incomplete | incomplete | incomplete |
12 | Describe the population & methods used to elicit preferences for outcomes | incomplete | incomplete | incomplete | incomplete | incomplete |
13 | Describe approaches & data sources for estimating resource use; describe research methods for valuing resource items as unit cost | incomplete | incomplete | incomplete | incomplete | incomplete |
14 | Give dates of est resource quantities & unit costs, methods for adjusting unit costs to year of reported costs & details regarding conversion to common currency base & exchange rate | incomplete | incomplete | incomplete | no | incomplete |
15 | Describe choice of model & reason for use. Provide figure of model structure. | yes | incomplete | yes | not applicable | incomplete |
16 | Describe all structural or other assumptions underpinning the decision-analytical model | yes | yes | yes | yes | yes |
17 | Describe methods for dealing with data issues, pooling data, extrapolation, model validation/adjustments & uncertainty | Incomplete | incomplete | incomplete | incomplete | incomplete |
| Â | Results | |||||
18 | Report values, ranges, references & probability distributions for all parameters & reasons/sources for distributions used for uncertainty | yes | incomplete | incomplete | incomplete | incomplete |
19 | For each intervention report mean values for estimated costs & outcomes, mean comparator differences & if applicable ICERs | yes | incomplete | incomplete | incomplete | yes |
20 | Describe uncertainty effect for parameters & uncertainty in relation to model structure and assumptions | incomplete | incomplete | incomplete | incomplete | incomplete |
21 | Describe effect of heterogeneities on cost, outcome or CE | yes | yes | yes | incomplete | yes |
| Â | Discussions | |||||
22 | Summarise findings, how they support conclusions, fit with current knowledge & their generalisability. Describe limitations | incomplete | incomplete | incomplete | incomplete | incomplete |
| Â | Other | |||||
23 | Describe sources of funding, role of funder & any other non-monetary sources of support | Yes | incomplete | incomplete | incomplete | incomplete |
24 | Describe potential for conflict of interest as per journal policy or as per recommendations of International Committee of Med Journal Editors | yes | yes | yes | yes | yes |